1. Home
  2. NTHI vs PINE Comparison

NTHI vs PINE Comparison

Compare NTHI & PINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTHI
  • PINE
  • Stock Information
  • Founded
  • NTHI 2008
  • PINE 2019
  • Country
  • NTHI United States
  • PINE United States
  • Employees
  • NTHI N/A
  • PINE N/A
  • Industry
  • NTHI Biotechnology: Pharmaceutical Preparations
  • PINE Real Estate Investment Trusts
  • Sector
  • NTHI Health Care
  • PINE Real Estate
  • Exchange
  • NTHI Nasdaq
  • PINE Nasdaq
  • Market Cap
  • NTHI 211.9M
  • PINE 205.4M
  • IPO Year
  • NTHI N/A
  • PINE 2019
  • Fundamental
  • Price
  • NTHI $9.80
  • PINE $14.68
  • Analyst Decision
  • NTHI
  • PINE Strong Buy
  • Analyst Count
  • NTHI 0
  • PINE 3
  • Target Price
  • NTHI N/A
  • PINE $17.17
  • AVG Volume (30 Days)
  • NTHI 42.0K
  • PINE 109.5K
  • Earning Date
  • NTHI 11-19-2025
  • PINE 10-23-2025
  • Dividend Yield
  • NTHI N/A
  • PINE 7.77%
  • EPS Growth
  • NTHI N/A
  • PINE N/A
  • EPS
  • NTHI N/A
  • PINE N/A
  • Revenue
  • NTHI $59,990.00
  • PINE $57,423,000.00
  • Revenue This Year
  • NTHI N/A
  • PINE $14.37
  • Revenue Next Year
  • NTHI N/A
  • PINE $0.71
  • P/E Ratio
  • NTHI N/A
  • PINE N/A
  • Revenue Growth
  • NTHI N/A
  • PINE 14.81
  • 52 Week Low
  • NTHI $3.20
  • PINE $13.10
  • 52 Week High
  • NTHI $25.00
  • PINE $18.57
  • Technical
  • Relative Strength Index (RSI)
  • NTHI N/A
  • PINE 65.52
  • Support Level
  • NTHI N/A
  • PINE $13.63
  • Resistance Level
  • NTHI N/A
  • PINE $14.80
  • Average True Range (ATR)
  • NTHI 0.00
  • PINE 0.31
  • MACD
  • NTHI 0.00
  • PINE 0.14
  • Stochastic Oscillator
  • NTHI 0.00
  • PINE 91.24

About NTHI NeOnc Technologies Holdings Inc. Common Stock

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).

About PINE Alpine Income Property Trust Inc.

Alpine Income Property Trust Inc is a real estate investment trust (REIT) that owns and operates a high-quality portfolio of commercial net lease properties in the United States. The company's portfolio predominantly comprises single-tenant retail properties located in or near metropolitan statistical areas, or MSAs. It operates in two business segments: income properties, which derive maximum revenue, and commercial loans and investments.

Share on Social Networks: